Cargando…

Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets

Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease of the esophagus characterized clinically by symptoms related to esophageal dysfunction and histologically by eosinophil-predominant inflammation, whose incidence is rising. It significantly affects patients’ quality of life and, if...

Descripción completa

Detalles Bibliográficos
Autores principales:	Racca, Francesca, Pellegatta, Gaia, Cataldo, Giuseppe, Vespa, Edoardo, Carlani, Elisa, Pelaia, Corrado, Paoletti, Giovanni, Messina, Maria Rita, Nappi, Emanuele, Canonica, Giorgio Walter, Repici, Alessandro, Heffler, Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790151/ https://www.ncbi.nlm.nih.gov/pubmed/35095572 http://dx.doi.org/10.3389/fphys.2021.815842

Ejemplares similares

Interleukin-5 in the Pathophysiology of Severe Asthma
por: Pelaia, Corrado, et al.
Publicado: (2019)

The Effect of Hyaluronic Acid and Chondroitin Sulphate-Based Medical Device Combined with Acid Suppression in the Treatment of Atypical Symptoms in Gastroesophageal Reflux Disease
por: Pellegatta, Gaia, et al.
Publicado: (2022)

New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine
por: Nappi, Emanuele, et al.
Publicado: (2022)

Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets
por: Pelaia, Corrado, et al.
Publicado: (2022)

Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms
por: Massironi, Sara, et al.
Publicado: (2023)

Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines
por: Nappi, Emanuele, et al.
Publicado: (2023)

Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model
por: Malipiero, Giacomo, et al.
Publicado: (2020)

Mast Cells in Upper and Lower Airway Diseases: Sentinels in the Front Line
por: Costanzo, Giovanni, et al.
Publicado: (2023)

Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions
por: Messina, Maria Rita, et al.
Publicado: (2023)

The Pathophysiology of Eosinophilic Esophagitis
por: Raheem, Mayumi, et al.
Publicado: (2014)

The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital
por: Paoletti, Giovanni, et al.
Publicado: (2023)

Evolution in Endoscopic Sinus Surgery: The Adjuvant Role of Reboot Surgery in Patients with Uncontrolled Nasal Symptoms of Eosinophilic Granulomatosis with Polyangiitis
por: Pirola, Francesca, et al.
Publicado: (2023)

Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs
por: Varricchi, Gilda, et al.
Publicado: (2016)

Oral Corticosteroid Abuse and Self-Prescription in Italy: A Perspective from Community Pharmacists and Sales Reports before and during the COVID-19 Era
por: Nappi, Emanuele, et al.
Publicado: (2023)

A multi-omic analysis reveals the esophageal dysbiosis as the predominant trait of eosinophilic esophagitis
por: Massimino, Luca, et al.
Publicado: (2023)

Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps
por: Paoletti, Giovanni, et al.
Publicado: (2022)

Eosinophilic esophagitis: which role for food and inhalant allergens?
por: Ridolo, Erminia, et al.
Publicado: (2012)

Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital()
por: Paoletti, Giovanni, et al.
Publicado: (2021)

Pathophysiology of Dysphagia in Eosinophilic Esophagitis: Causes, Consequences, and Management
por: Young, Edward, et al.
Publicado: (2022)

An academic allergy unit during COVID-19 pandemic in Italy
por: Malipiero, Giacomo, et al.
Publicado: (2020)

The Present and Future of Allergen Immunotherapy in Personalized Medicine
por: Ridolo, Erminia, et al.
Publicado: (2022)

Critical evaluation of asthma biomarkers in clinical practice
por: Guida, Giuseppe, et al.
Publicado: (2022)

Evaluation of Human Esophageal Epithelium Permeability in Presence of Different Formulations Containing Hyaluronic Acid and Chondroitin Sulphate
por: Pellegatta, Gaia, et al.
Publicado: (2020)

Biologics and airway remodeling in severe asthma
por: Varricchi, Gilda, et al.
Publicado: (2022)

Prevalence of familial link in patients affected by chronic rhinosinusitis with nasal polyposis
por: Giombi, Francesco, et al.
Publicado: (2022)

Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma
por: Vatrella, Alessandro, et al.
Publicado: (2022)

A critical appraisal on AIT in childhood asthma
por: Ferrando, Matteo, et al.
Publicado: (2018)

Use, Abuse, and Misuse of Nasal Medications: Real-Life Survey on Community Pharmacist’s Perceptions
por: Russo, Elena, et al.
Publicado: (2023)

Eosinophilic esophagitis in children: doubts and future perspectives
por: Cavalli, Elena, et al.
Publicado: (2019)

Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis
por: Heffler, Enrico, et al.
Publicado: (2020)

Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
por: Solidoro, Paolo, et al.
Publicado: (2022)

Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis
por: Di Bona, Danilo, et al.
Publicado: (2021)

Cutting Edge: Biomarkers for Chronic Spontaneous Urticaria
por: Folci, Marco, et al.
Publicado: (2018)

Real-world data: A relevant component in the framework of scientific evidence
por: Canonica, Giorgio W., et al.
Publicado: (2023)

Immunostimulants in respiratory diseases: focus on Pidotimod
por: Puggioni, Francesca, et al.
Publicado: (2019)

Nasal Polyposis Quality of Life (NPQ): Development and Validation of the First Specific Quality of Life Questionnaire for Chronic Rhinosinusitis with Nasal Polyps
por: Baiardini, Ilaria, et al.
Publicado: (2022)

Peroral endoscopic myotomy (POEM) for achalasia developing after vertical banded gastroplasty with asymptomatic gastro-gastric fistula
por: Vespa, Edoardo, et al.
Publicado: (2022)

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab
por: Pelaia, Corrado, et al.
Publicado: (2017)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021)

Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
por: Portacci, Andrea, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_89tuehm80ob1ab2mkdc9ie1u4p